NCT01992094 Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older Status COMPLETED Phase PHASE3
NCT01990846 Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01987349 T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009 Status COMPLETED Phase PHASE4
NCT01987011 Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers Status COMPLETED Phase PHASE3
NCT01985620 The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate. Status UNKNOWN Phase NA
NCT01984125 Testing the Use of Prompts to Increase Adolescent Immunization Rates Status COMPLETED Phase NA
NCT01982331 Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza Vaccine Status COMPLETED Phase PHASE1
NCT01974895 Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age Status COMPLETED Phase PHASE2
NCT01971255 Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People Status COMPLETED Phase PHASE1/PHASE2
NCT01967784 Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan Status COMPLETED Phase PHASE3
NCT01959945 Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation) Status COMPLETED Phase PHASE3
NCT01949090 Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older Status COMPLETED Phase PHASE2
NCT01946438 Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults Status COMPLETED Phase PHASE4
NCT01946425 Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine Status COMPLETED Phase PHASE4
NCT01945424 Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry Status COMPLETED Phase N/A